Earnest Partners LLC reduced its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 2.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,261,808 shares of the medical instruments supplier's stock after selling 36,886 shares during the quarter. Earnest Partners LLC owned approximately 0.63% of DENTSPLY SIRONA worth $23,949,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also modified their holdings of the company. Riverview Trust Co purchased a new stake in shares of DENTSPLY SIRONA in the fourth quarter valued at about $26,000. MassMutual Private Wealth & Trust FSB grew its stake in shares of DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after buying an additional 1,232 shares during the period. UMB Bank n.a. increased its holdings in shares of DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after buying an additional 564 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after acquiring an additional 1,568 shares during the last quarter. Finally, Signaturefd LLC raised its position in DENTSPLY SIRONA by 513.3% in the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock valued at $84,000 after purchasing an additional 3,706 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.
Insider Activity at DENTSPLY SIRONA
In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, March 3rd. The stock was purchased at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the transaction, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.52% of the stock is owned by insiders.
Analyst Ratings Changes
XRAY has been the subject of a number of research analyst reports. Morgan Stanley cut shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a research report on Tuesday, April 15th. Robert W. Baird lowered their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a report on Friday, February 28th. Wells Fargo & Company cut their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research note on Friday, February 28th. Piper Sandler lowered their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday. Finally, Mizuho lowered their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Thursday, March 13th. Thirteen analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, DENTSPLY SIRONA has a consensus rating of "Hold" and an average target price of $21.25.
Read Our Latest Stock Report on XRAY
DENTSPLY SIRONA Stock Up 0.2 %
Shares of NASDAQ:XRAY traded up $0.03 during trading on Thursday, hitting $13.93. 3,200,700 shares of the company were exchanged, compared to its average volume of 2,979,551. The stock has a market capitalization of $2.78 billion, a P/E ratio of -6.73, a PEG ratio of 1.80 and a beta of 0.92. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $29.89. The firm's 50 day moving average price is $14.69 and its 200-day moving average price is $18.04.
DENTSPLY SIRONA Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were given a $0.16 dividend. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.59%. DENTSPLY SIRONA's dividend payout ratio (DPR) is -14.07%.
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.